OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(25)
Publication Date
Release Date
2021
(6)
2025
(4)
2023
(3)
2022
(3)
2024
(2)
2019
(2)
2015
(2)
2018
(1)
2014
(1)
2013
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Inflammation induces dermal Vγ4+ γδT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses.
Not available
S-EPMC4491769
|
biostudies-literature
Cite
Sphingosine-1-phosphate receptor 2 restrains egress of γδ T cells from the skin.
Not available
S-EPMC6605748
|
biostudies-literature
Cite
Deficiency in IL-17-committed Vγ4(+) γδ T cells in a spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides protection from dermatitis.
Not available
S-EPMC3660499
|
biostudies-literature
Cite
Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
Not available
S-EPMC4374671
|
biostudies-literature
Cite
Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease.
Not available
S-EPMC10794000
|
biostudies-literature
Cite
Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
Not available
S-EPMC7885035
|
biostudies-literature
Cite
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.
Not available
S-EPMC6439620
|
biostudies-literature
Cite
COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.
Not available
S-EPMC10569976
|
biostudies-literature
Cite
Incidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online survey.
Not available
S-EPMC4057509
|
biostudies-literature
Cite
Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Not available
S-EPMC9673084
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets